Offered by: Nemours Children's
Locations: Jacksonville, Fla.; Pensacola, Fla.
Phase III Randomized Study of Chimeric Antibody 14.18 (Ch14.18) in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue
Evaluate an investigational treatment aimed at maintaining or improving your child’s response to previous treatments.
Children undergoing treatment for high risk neuroblastoma.
Length of study is six months. Tests and procedures performed include: Physical exam; Blood tests; Bone marrow tests; Various scans; Tests of kidney function; Tests of lung and heart function; Urine tests.
Nemours has a number of service regions. Selecting your region will help us show you the right contact information and the most relevant content for you.